Matplus, Ltd. – Trademark Portfolio

Entity Type: 16

Matplus, Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 17 (Rubber Goods) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include SOLEAID. The owner is based in Painesville, OH.

76 Burton Street

Painesville, OH 44077

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MATPLUS
MATPLUS
Pending 2026
SOLEAID
SOLEAID
Registered 2019

Trademark Classifications

Matplus, Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

17
Rubber Goods (1 filing)

Unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does Matplus, Ltd. have?

Matplus, Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Matplus, Ltd. file in?

Matplus, Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 17 (Rubber Goods), Class 40 (Treatment & Processing). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Matplus, Ltd.'s most well-known trademarks?

Matplus, Ltd.'s registered trademark portfolio includes well-known marks such as SOLEAID. These are among 1 currently registered trademark in the portfolio.

What is Matplus, Ltd.'s trademark registration success rate?

Matplus, Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.